AstraZeneca Entered into a Two-Year Collaboration with Thorne HealthTech for Disease Discovery System to Advance Novel Product Development

Shots:

The collaboration focuses on Thorne’s disease discovery platform into AZ for further analysis, gaining insight for additional uses of AZ molecules & will identify novel and biologically plausible drug targets
The collaboration will provide innovative AI-driven technologies for drug discovery & will identify novel and biologically plausible drug targets. Thorne’s cloud-based AI illness discovery engine combines evidence from biology & chemistry to produce compound discoveries for new product development in the pharmaceutical & nutrition industries
The system uses a multi-omic platform & Thorne’s AI model which have been validated by numerous independent clinical studies in peer-reviewed publications

Ref: PR Newswire | Image: AstraZeneca